NASDAQ
Global Blood Therapeutics, Inc. (GBT) has a current ratio of 9.11x as of Tuesday, May 26, 2026. This represents a 16.24% decrease compared to its 12-month average of 10.88x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.